Health Catalyst, Inc.
HCAT
$3.38
$0.000.00%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -72.60% | -14.85% | -40.38% | -8.95% | 34.35% |
Total Depreciation and Amortization | 2.80% | 21.30% | 3.78% | -10.46% | 2.86% |
Total Amortization of Deferred Charges | -5.53% | 11.69% | -3.69% | 42.50% | -3.56% |
Total Other Non-Cash Items | 305.56% | -12.41% | 25.99% | -24.01% | -33.61% |
Change in Net Operating Assets | -643.10% | 175.45% | -238.86% | 145.08% | -194.99% |
Cash from Operations | -3,313.21% | 107.94% | -156.81% | 285.11% | -84.30% |
Capital Expenditure | 134.33% | -62.23% | 41.42% | -143.10% | -39.42% |
Sale of Property, Plant, and Equipment | 157.14% | 133.33% | 0.00% | -25.00% | 33.33% |
Cash Acquisitions | 100.02% | -61.97% | 29.93% | -94.17% | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -137.88% | 259.34% | -295.05% | 159.75% | -79.61% |
Cash from Investing | -153.97% | 185.82% | -1,574.61% | 528.83% | -102.12% |
Total Debt Issued | -- | -- | -68.13% | -- | -- |
Total Debt Repaid | -56,511.06% | -30.03% | 51.55% | -- | -- |
Issuance of Common Stock | -55.68% | 98.57% | -47.68% | -4.15% | -19.12% |
Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | 128.27% | -- | -- |
Cash from Financing | -4,783.26% | -112.50% | -66.50% | 16,016.76% | -19.12% |
Foreign Exchange rate Adjustments | 1,028.57% | 92.71% | -215.66% | 4,250.00% | 89.47% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -415.48% | 217.34% | -162.23% | 23,982.29% | -99.45% |